Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICAL, VAGINALStandard

PREMARIN

ESTROGENS, CONJUGATED

Standard Dose
0.625MG/GM
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview PREMARIN is listed in Drugs@FDA under application 020216 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ESTROGENS, CONJUGATED Form and strength CREAM;TOPICAL, VAGINAL - 0.625MG/GM Sponsor WYETH PHARMS Submission history Latest submission status date: 2025-04-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview PREMARIN is listed in Drugs@FDA under application 020216 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ESTROGENS, CONJUGATED Form and strength CREAM;TOPICAL, VAGINAL - 0.625MG/GM Sponsor WYETH PHARMS Submission history Latest submission status date: 2025-04-22 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.